A Narrative Review: Molecular Docking Simulation of Antiviral Drugs as Anti-COVID-19 Candidates

Author:

Muchtaridi Muchtaridi1,Rizki Ananda Adham1,Raihan Fajri1,Permata Rendi Indah1,Suhandi Cecep1,Rahayu Driyanti1

Affiliation:

1. Department of Pharmaceutical Analysis and Medicinal Chemistry, Faculty of Pharmacy, Universitas Padjadjaran, Jatinangor, Indonesia.

Abstract

COVID-19 is a disease caused by SARS-CoV-2 and since 2020 has become a pandemic by affecting at least millions of people with a mortality rate of over 4 million worldwide. COVID-19 has fourteen drug targets with main protease (Mpro) as the most potential enzyme for inhibition. There is a catalytic dyad in Mpro which is the main key to determine the inhibitory potential of a ligand in COVID-19. Currently, the drug for Mpro inhibition in COVID-19 has not been found. Many articles have been published discussing the interaction and inhibitory potential of drugs against Mpro in COVID-19, so it is necessary to draw a conclusion to select drug candidates with the best potency. PMC and ScienceDirect are two databases used for article screening. Research using molecular docking simulation of Mpro with Gibbs energy parameters and the interaction between the ligand and Mpro is the focus of this review. Compounds that achieve the docking parameters are carefully ranked. There are 28 articles with a total of 118 compounds that achieve the docking parameters ranked. The top three compounds were dihydroergotoxine (ΔG = -10.14kcal/mol), imatinib (ΔG = -10.12kcal/mol), and hyaluronic acid (ΔG = -13.54 kcal/mol) with the highest binding mode and inhibitory potential on catalytic dyads. These compounds need to be considered for further research.

Publisher

A and V Publications

Subject

Pharmacology (medical),Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3